Table 2.

Association of the PvuII genotypes separately and the outcome of COH/IVF in the homogenous rFSH dose group (100 IU per day)

Variables	Pvu II C/T - rs2234693
	TT						TC CC					χ 2 p
	N	Median	Minimum	Maximum	N	Median	Minimum	Maximum	N	Median	Minimum	Maximum
Age (years)	16	33,5	27	37	54	32	26	37	35	31	24	37	0,41	0,521
BMI (kg/m2)	14	22,23	16,8	28,73	52	24,46	17,71	31,62	35	23,9	19,49	31,14	2,72	0,26
Estradiol (pg/ml)	16	39,67	27,06	253,58	54	46,445	28,14	346,9	35	45,53	28,66	90,22	1,99	0,37
Follicles	16	4	0	15	54	6	0	19	35	5	0	28	0,97	0,62
Oocytes	15	4	0	15	49	6	0	19	33	5	0	28	1,13	0,57
Mature oocytes	15	4	0	15	49	4	0	17	33	4	0	25	0,89	0,64
Embryos	13	4	0	14	43	3	0	14	30	4	1	17	1,66	0,44
Good quality embryos	12	1,5	0	7	43	2	0	11	30	3	0	12	1,23	0,54
Days of rFSH	13	10	9	14	45	9	7	13	31	9	8	12	8,06	0,018*
Dose of rFSH (UI)	13	1000	900	1400	45	900	700	1300	31	900	800	1200	8,06	0,018*

N: Number of Individuals; SD: Standard deviation; *p < 0.05. Results of Kruskal-Wallis (represented by χ ²).